Clinical trial
Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of…
NCT00169598 · Hospices Civils de Lyon, Other · Unknown status
Key facts
| NCT number | NCT00169598 |
|---|---|
| Title | Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study |
| Official title | Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study |
| Acronym | TEPELY |
| Lead sponsor | Hospices Civils de Lyon, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Procedure |
| Interventions | positron emission tomography |
| Enrollment | 80 |
| Start date | Feb 1, 2002 |
| First posted | Sep 15, 2005 |
| Last update posted | Apr 27, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: